PCAT6 and osteosarcoma: In addition, PCAT6 has been shown to be aberrantly expressed in osteosarcoma [23], ovarian [24], lung [25], colorectal [21], cervical [26], and pancreatic ductal cancers [27], thereby suggesting that PCAT6 is associated with the clinicopathological characteristics and prognosis of tumors.